Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125582651 | 12558265 | 1 | I | 20160705 | 20160705 | 20160714 | 20160714 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-057026 | BRISTOL MYERS SQUIBB | 60.17 | YR | M | Y | 0.00000 | 20160714 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125582651 | 12558265 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 20 MG, UNK | U | 21436 | 20 | MG | TABLET | ||||||
| 125582651 | 12558265 | 2 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125582651 | 12558265 | 3 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125582651 | 12558265 | 1 | Post-traumatic stress disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125582651 | 12558265 | Aggression | |
| 125582651 | 12558265 | Anxiety | |
| 125582651 | 12558265 | Fear | |
| 125582651 | 12558265 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |